<DOC>
	<DOCNO>NCT02251158</DOCNO>
	<brief_summary>Study determine relative bioavailability 500/200 mg tipranavir/ritonavir ( TPV/r ) oral solution compare 500/200 mg TPV/r capsule follow oral administration investigate relative bioavailability 500/200 mg TPV/r oral solution food versus without food .</brief_summary>
	<brief_title>Bioavailability Tipranavir/Ritonavir Paediatric Solution Compared Tipranavir/Ritonavir Capsules Healthy Female Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<criteria>1 . Healthy male female accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , HR ) , 12lead ECG , clinical laboratory test No find deviate normal clinical relevance No evidence clinically relevant concomitant disease 2 . Age ≥ 18 Age ≤ 55 year 3 . BMI ≥ 18.5 BMI ≤ 29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Surgery gastrointestinal tract ( except appendectomy ) 3 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 4 . History relevant orthostatic hypotension , faint spell blackouts 5 . Chronic relevant acute infection 6 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 7 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial 8 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial ( e.g . drug contain polyethylene glycol vitamin E ) 9 . Participation another trial investigational drug within two month prior administration trial 10 . Smoker ( 10 cigarettes/day 3 cigars/day 3 pipes/day ) 11 . Inability refrain smoke trial day 12 . Alcohol abuse ( 60 g/day ) 13 . Drug abuse 14 . Veins unsuited iv puncture either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture ) 15 . Blood donation ( 100 mL within four week prior administration trial ) 16 . History bleed disorder acute blood coagulation defect vitamin K deficiency cause anticoagulation therapy malabsorption 17 . Vitamin E supplement intake 18 . Excessive physical activity ( within one week prior administration trial ) 19 . Any laboratory value outside reference range clinical relevance 20 . Inability comply dietary regimen study centre For female subject : 21 . Pregnancy 22 . Positive pregnancy test 23 . No adequate contraception e.g . oral contraceptive , sterilization , intrauterine device 24 . Inability maintain adequate contraception whole study period 25 . Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>